OVERVIEW 2026
The treatment of lung cancer is evolving rapidly. Our annual meeting provides an update on data from major national and international conferences, allowing experts and participants to discuss the latest findings, put them in context and really understand how they affect our daily practice. Participants will have the opportunity to engage with faculty members who will share their views on the main controversies surrounding the management of lung cancer. Leading experts in the treatment of lung cancer will share their ideas and knowledge with congress participants with the ultimate goal of mutual enrichment.
PRESIDENT OF THE CONFERENCE
Giuseppe Lo Russo, MD PhD Thoracic Unit, Medical Oncology Fondazione IRCCS Istituto Nazionale dei Tumori, Milano IT
HOW TO PARTECIPATE/ECM
The conference will be held in a hybrid mode, with participants attending both in presence and online.
OFFICIAL LANGUAGE: The official language is English.
OFFICIAL TIME: UTC +1 / Central European Time (CET)
